PTGX - Protagonist Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-05    (Delayed quote data   2025-09-15)
Last
 58.38		 Change
 ⇓ -0.48   (-0.82%)		 Volume
  929,176
Open
 58.86		 High
 59.64		 Low
 57.95
8EMA (Daily)
 58.55		 40EMA (Daily)
 56.50		 50EMA (Daily)
 55.87		 STO (Daily)
 55.535		 MACD Hist (Daily)
 -0.242
8EMA (Weekly)
 57.368		 40EMA (Weekly)
 49.68		 50EMA (Weekly)
 47.88		 STO (Weekly)
 83.203		 MACD Hist (Weekly)
 0.501
Company Profile
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com